IMUX
Dr. med. Andreas Rolf Mühler
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. med. Andreas Rolf Mühler
Immunic, Inc. reported in an 8-K filed December 21, 2023 that Dr. med. Andreas Rolf Mühler was appointed Chief Medical Officer (CMO), effective January 1, 2024.
“Dr. Andreas Rolf Mühler is appointed as Chief Medical Officer (CMO) of the Company for the Term and represents the Company together with a member of the Management Board or an authorized signatory.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Immunic, Inc. (IMUX)
SEC 8-K
Current2024-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Immunic, Inc.
Other people whose current roles at this company are on record from its filings.
- Dr. Daniel Vitt CEO
- Duane D. Nash CEO
- Duane Nash CEO
- Erik Lundgren CEO, Board Member
- Russell J. Cox CEO
- Michael W. Bonney Chairman
- Simona Skerjanec Chairman, Board Member
- Glenn Whaley CFO
- Jason Tardio COO
- Inderpal Singh General Counsel
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.